Volume No. :   4

Issue No. :  4

Year :  2013

ISSN Print :  0976-2973

ISSN Online :  2321-581X


Registration

Allready Registrered
Click to Login

Emerging Trends in Artificial Blood



Address:   K. Saranya*, V. Manivasagan, N.G. Ramesh Babu, D. Pradeep, S. Pandidurai
Department of Biotechnology, Adhiyamaan College of Engineering, Hosur.
*Corresponding Author
DOI No:

ABSTRACT:
Blood substitutes are currently undergoing preliminary clinical trials to determine their safety. Two distinctly different classes of oxygen carriers are being developed, each capable of transporting and delivering oxygen to peripheral tissues. The delivery of oxygen by these two methodologies may have both benefits and risks which are unique to its class. Early clinical trials have been promising. However, effective use of these blood substitutes may involve using them in conjunction with other techniques such as normovolemic hemodilution to effectively reduce or eliminate the need for transfusions in certain instances. However, this first generation of clinically safe blood substitutes will not replace allogeneic blood transfusions as a means of treating many types of anemia.
KEYWORDS:
Hemoglobin-based oxygen carriers (HBOCs), perfluorocarbon-based oxygen carriers (PFBOCs),Blood substitute, Blood pharming
Cite:
K. Saranya, V. Manivasagan, N.G. Ramesh Babu, D. Pradeep, S. Pandidurai. Emerging Trends in Artificial Blood. Research J. Engineering and Tech. 4(4): Oct.-Dec., 2013 page 199-207.
[View HTML]      [View PDF]



Visitor's No. :   164456